Toxins of Clostridium perfringens;Toxinas de Clostridium perfringens

Revista Argentina de Microbiologia

Volumn 41, Issue 4, 2009, Pages 251-260

  Morris, W E ^a   Fernandez Miyakawa M E ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Clostridium perfringens; Enterotoxemia; Toxins

Indexed keywords

ALPHA TOXIN; CLOSTRIDIUM TOXIN;

BACTERIUM ISOLATION; CLOSTRIDIUM PERFRINGENS; DYSENTERY; ENTEROTOXEMIA; FOOD POISONING; GAS GANGRENE; GOAT; INTESTINE FLORA; NECROTIZING COLITIS; NECROTIZING ENTERITIS; NONHUMAN; PAPUA NEW GUINEA; REVIEW; SHEEP; SOIL; WATER SAMPLING;

ANIMAL DISEASES; ANIMALS; BACTERIAL TOXINS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; ENTERITIS; ENTEROTOXINS; ENVIRONMENTAL MICROBIOLOGY; FOOD MICROBIOLOGY; HUMANS; INTESTINES;

EID: 76749168967     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. Adamson RH, Ly JC, Fernández-Miyakawa M, Ochi S, Sakurai J, Uzal F, et al. Clostridium perfringens epsilon-toxin increases permeability of single perfused microvessels of rat mesentery. Infect Immun 2005; 73: 4879-87.
2. Al-Sheikhly F, Truscott RB. The pathology of necrotic enteritis of chickens following infusion of crude toxins of Clostridium perfringens into the duodenum. Avian Dis 1977; 21: 241-55.
3. Baba E, Fuller AL, Gilbert JM, Thayer SG, McDougald LR. Effects of Eimeria brunetti infection and dietary zinc on experimental induction of necrotic enteritis in broiled chickens. Avian Dis 1992; 36: 59-62.
4. Barbara AJ, Trinh HT, Glock RD, Songer JG. Necrotic enteritis-producing strains of Clostridium perfringens displace non-necrotic enteritis strains from the gut of chicks. Vet Microbiol 2008; 126: 377-82.
5. Barth H, Stiles BG. Binary actin-ADP-ribosylating toxins and their use as molecular Trojan horses for drug delivery into eukaryotic cells. Curr Med Chem 2008; 15: 459-69.
6. Batty I, Bullen JJ. The effect of Clostridium welchii type D culture filtrates on the permeability of the mouse intestine. J Pathol Bacteriol 1956; 71: 311-23.
7. Billington SJ, Wieckowski EU, Sarker MR, Bueschel D, Songer JG, McClane BA. Clostridium perfringens type E animal enteritis isolates with highly conserved, silent enterotoxin gene sequences. Infect Immun 1998; 66: 4531-6.
8. Borriello SP, Carman RJ. Association of iota-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits. J Clin Microbiol 1983; 17: 414-8.
9. Borriello SP, Larson HE, Welch AR, Barclay F, Stringer MF, Bartholomew BA. Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet 1984; 8372: 305-7.
10. Borrmann E, Günther H, Köhler H. Effect of Clostridium perfringens epsilon toxin on MDCK cells. FEMS Immunol Med Microbiol 2001; 31: 85-92.
11. Brown CC, Baker DC, Barker IK. The alimentary system. In: MG Maxie, editor. Jubb, Kennedy and Palmer's pathology of domestic animals. Vol. 2, 50 ed.; Elsevier, 2007, p. 771.
12. Brynestad S, Synstad B, Granum PE. The Clostridium perfringens enterotoxin gene is on a transposable element in type A human food poisoning strains. Microbiology 1997; 143: 2109-15.
13. Bullen JJ, Batty I. Experimental enterotoxaemia of sheep: the effect of the permeability of the intestine and the stimulation of antitoxin production in immune animals. J Pathol Bacteriol 1957; 73: 511-8.
14. Cabiaux V, Buckley JT, Wattiez R, Ruysschaert JM, Parker MW, van der Goot FG. Conformational changes in aerolysin during the transition from the water-soluble protoxin to the membrane channel. Biochemistry 1997; 36: 15224-32.
15. Canard B, Cole ST. Genome organization of the anaerobic pathogen Clostridium perfringens. Proc Natl Acad Sci USA 1989; 86: 6676-80.
16. Carman RJ, Perelle S, Popoff MR. Binary toxins from Clostridium spiroforme and Clostridium perfringens, In: Rood JI, McClane BA, Songer JG, Titball RW, editors. The clostridia: molecular biology and pathogenesis. London, UK, Academic Press, 1997, p. 359-67.
17. Chakrabarti G, Zhou X, McClane BA. Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin. Infect Immun 2003; 71: 4260-70.
18. Chassin C, Bens M, de Barry J, Courjaret R, Bossu JL, Cluzeaud F, et al. Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am J Physiol Renal Physiol 2007; 293: 927-37.
19. Cole AR, Gibert M, Popoff M, Moss DS, Titball RW, Basak AK. Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat Struct Mol Biol 2004; 11: 797-8.
20. Collie RE, McClane BA. Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases. J Clin Microbiol 1998; 36: 30-6.
21. Collins JE, Bergeland ME, Bouley D, Ducommun AL, Francis DH, Yeske P. Diarrhea associated with Clostridium perfringens type A enterotoxin in neonatal pigs. J Vet Diagn Invest 1989; 1: 351-3.
22. Cornillot E, Saint-Joanis B, Daube G, Katayama S, Granum PE, Canard B, et al. The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne. Mol Microbiol 1995; 15: 639-47.
23. Czeczulin JR, Hanna PC, McClane BA. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect Immun 1993; 61: 3429-39.
24. Fernández Miyakawa ME, Ibarra CA, Uzal FA. In vitro effects of Clostridium perfringens type D epsilon toxin on water and ion transport in ovine and caprine intestine. Anaerobe 2003; 9: 145-9.
25. Fernández Miyakawa ME, Uzal FA. Morphologic and physiologic changes induced by Clostridium perfringens type A alpha toxin in the intestine of sheep. Am J Vet Res 2005; 66: 251-5.
26. Fernández-Miyakawa ME, Marcellino R, Uzal FA. Clostridium perfringens type A toxin production in 3 commonly used culture media. J Vet Diagn Invest. 2007; 19: 184-6.
27. Ferrarezi MC, Cardoso TC, Dutra IS. Genotyping of Clostridium perfringens isolated from calves with neonatal diarrhea. Anaerobe 2008; 14: 328-31.
28. Finnie JW. Neurological disorders produced by Clostridium perfringens type D epsilon toxin. Anaerobe 2004; 10: 145-50.
29. Fisher DJ, Miyamoto K, Harrison B, Akimoto S, Sarker MR, McClane BA. Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol Microbiol 2005; 56: 747-62.
30. Fisher DJ, Fernández-Miyakawa ME, Sayeed S, Poon R, Adams V, Rood JI, et al. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect Immun 2006; 74: 5200-10.
31. Fujii Y, Nomura S, Oshita Y, Sakurai J. Excitatory effect of Clostridium perfringens alpha toxin on the rat isolated aorta. Br J Pharmacol 1986; 88: 531-9.
32. Fujii Y, Sakurai J. Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism. Br J Pharmacol 1989; 97: 119-24.
33. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 2000; 476: 258-61.
34. Fukata T, Hadate Y, Baba E, Arakawa A. Influence of bacteria on Clostridium perfringens infections in young chickens. Avian Dis 1991; 35: 224-7.
35. Gardner DE. Pathology of Clostridium welchii type D enterotoxaemia. II. Structural and ultrastructural alterations in the tissues of lambs and mice. J Comp Pathol 1973; 83: 509-24
36. Gibert, M.; Jolivet-Renaud, C.; Popoff, M.R. Beta-2 toxin, a novel toxin produced by Clostridium perfringens. Gene 1997; 203: 65-73.
37. Gkiourtzidis K, Frey J, Bourtzi-Hatzopoulou E, Iliadis N, Sarris K. PCR detection and prevalence of alpha-, beta-, beta 2-, epsilon-, iota- and enterotoxin genes in Clostridium perfringens isolated from lambs with clostridial dysentery. Vet Microbiol 2001; 82: 39-43.
38. Gouaux E. Alpha-hemolysin from Staphylococcus aureus: an archetype of beta-barrel, channel-forming toxins. J Struct Biol 1998; 121: 110-22.
39. Hale ML, Marvaud JC, Popoff MR, Stiles BG. Detergent-resistant membrane microdomains facilitate Ib oligomer formation and biological activity of Clostridium perfringens Iota-toxin. Infect Immun 2004, 72, 4: 2186-93.
40. Hardy SP, Denmead M, Parekh N, Granum PE. Cationic currents induced by Clostridium perfringens type A enterotoxin in human intestinal CaCO-2 cells. J Med Microbiol 1999; 48: 235-43.
41. Hauschild AH, Hilsheimer R. Purification and characteristics of the enterotoxin of Clostridium perfringens type A. Can J Microbiol 1971; 17: 1425-33.
42. Herholz C, Miserez R, Nicolet J, Frey J, Popoff M, Gibert M, et al. Prevalence of beta2-toxigenic Clostridium perfringens in horses with intestinal disorders. J Clin Microbiol 1999; 37: 358-61.
43. Holdsworth RJ, Parratt D. The potential role of Clostridium perfringens alpha toxin in the pathogenesis of acute pancreatitis. J Clin Pathol 1996; 49: 500-3.
44. Hughes ML, Poon R, Adams V, Sayeed S, Saputo J, Uzal FA, et al. Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative. J Bacteriol 2007; 189: 7531-8.
45. Iwanaka T, Kawashima H, Kishimoto H, Kakinuma M, Arai K, Sakurai J, et al. Enteritis necroticans caused by Clostridium perfringens type A. J Pediatr 2004; 144: 410-4.
46. Johnson S, Gerding DN. Enterotoxemic infections. In: Rood JI, MCClane BA, Songer JG, editors. The Clostridia: Molecular Biology and Pathogenesis. London, UK, Academic Press, 1997, p. 117-40.
47. Kamaras J, Murrell WG. Intestinal epithelial damage in SIDS babies and its similarity to that caused by bacterial toxins in the rabbit. Pathology 2001; 33: 197-203
48. Kanoe M, Inoue S, Abe T, Anzai T, Kamada M, Imagawa H, et al. Isolation of Clostridium perfringens from foals. Microbios 1990; 64: 153-8.
49. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 1997a. 24; 136: 1239-47.
50. Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 1997b; 272: 26652-8.
51. Katayama S, Dupuy B, Daube G, China B, Cole ST. Genome mapping of Clostridium perfringens strains with I-CeuI shows many virulence genes to be plasmid-borne. Mol Gen Genet 1996; 251: 720-6.
52. Keyburn AL, Sheedy SA, Ford ME, Williamson MM, Awad MM, Rood JI, et al. Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect Immun 2006; 74: 6496-500.
53. Keyburn AL, Boyce JD, Vaz P, Bannam TL, Ford ME, Parker D, et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog 2008; 4: e26, 1-11.
54. Kokai-Kun JF, McClane BA. Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes. Infect Immun 1996; 64: 1020-5.
55. Kominsky SL, Tyler B, Sosnowski J, Brady K, Doucet M, Nell D, et al. Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis. Cancer Res 2007; 67: 7977-82.
56. Kruth SA, Prescott JF, Welch MK, Brodsky MH. Nosocomial diarrhea associated with enterotoxigenic Clostridium perfringens infection in dogs. J Am Vet Med Assoc 1989; 195: 331-4.
57. Lawrence G, Walker PD. Pathogenesis of enteritis necroticans in Papua New Guinea. Lancet 1976; 1: 125-6.
58. Long JR, Truscott RB. Necrotic enteritis in broiler chickens. III. Reproduction of the disease. Can J Comp Med 1976; 40: 53-9.
59. Ludwig A, Bauer S, Benz R, Bergmann B, Goebel W. Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12. Mol Microbiol 1999; 31: 557-67.
60. Manteca C, Daube G, Jauniaux T, Linden A, Pirson V, Detilleux J, et al. A role for the Clostridium perfringens beta2 toxin in bovine enterotoxaemia? Vet Microbiol 2002; 86: 191-202.
61. Mantis NJ. Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin. Adv Drug Deliv Rev 2005; 57: 1424-39.
62. Marvaud JC, Stiles BG, Chenal A, Gillet D, Gibert M, Smith LA, et al. Clostridium perfringens iota toxin. Mapping of the Ia domain involved in docking with Ib and cellular internalization. J Biol Chem 2002; 277: 43659-66.
63. Matsuda T, Okada Y, Inagi E, Tanabe Y, Shimizu Y, Nagashima K, et al. Enteritis necroticans 'pigbel' in a Japanese diabetic adult. Path Int 2007; 57: 622-6.
64. Matsushita C, Matsushita O, Katayama S, Minami J, Takai K, Okabe A. An upstream activating sequence containing curved DNA involved in activation of the Clostridium perfringens plc promoter. Microbiology 1996; 142: 2561-6.
65. McClane BA, McDonel JL. Protective effects of osmotic stabilizers on morphological and permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin. Biochim Biophys Acta 1981; 641: 401-9
66. McClane BA, Uzal FA, Miyakawa MF, Lyerly D, Wilkins T. The Enterotoxic Clostridia. In: Dworkin M, Falkow S, Rosenburg E, Schleifer KH, Stackebrandt E, editors. The Prokaryotes, Vol. 4. New York, Springer-Verlag, 2006, p. 698-752.
67. McCourt MT, Finlay DA, Laird C, Smyth JA, Bell C, Ball HJ. Sandwich ELISA detection of Clostridium perfringens cells and alpha-toxin from field cases of necrotic enteritis of poultry. Vet Microbiol 2005; 106: 259-64.
68. McDonel JL, Duncan CL. Histopathological effect of Clostridium perfringens enterotoxin in the rabbit ileum. Infect Immun 1975; 12: 1214-8.
69. Michl P, Gress TM. Bacteria and bacterial toxins as therapeutic agents for solid tumors. Curr Cancer Drug Targets 2004; 4: 689-702.
70. Minami J, Katayama S, Matsushita O, Matsushita C, Okabe A. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol Immunol 1997; 41: 527-35.
71. Miyamoto O, Minami J, Toyoshima T, Nakamura T, Masada T, Nagao S, et al. Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system. Infect Immun 1998; 66: 2501-8.
72. Miyamoto O, Sumitani K, Nakamura T, Yamagami S, Miyata S, Itano T, et al. Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol Lett 2000; 189: 109-13.
73. Miyata S, Matsushita O, Minami J, Katayama S, Shimamoto S, Okabe A. Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane. J Biol Chem 2001; 276: 13778-83.
74. Morgan KT, Kelly BG, Buxton D Vascular leakage produced in the brains of mice by Clostridium welchii type D toxin. J Comp Pathol 1975; 85: 461-6
75. Nabuurs MJ, Haagsma J, Van de Molen EJ, Van der Heijden PJ. Diarrhea in one to three week-old piglets associated with Clostridium perfringens type A. Ann Rech Vet 1983; 14: 408-11.
76. Nagahama M, Iida H, Sakurai J. Effect of Clostridium perfringens epsilon toxin on rat isolated aorta. Microbiol Immunol 1993; 37: 447-50.
77. Nagahama M, Nakayama T, Michiue K, Sakurai J. Sitespecific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities. Infect Immun 1997; 65: 3489-92.
78. Niilo L. Mechanism of Action of the enteropathogenic factor of Clostridium perfringens type A. Infect Immun 1971; 3: 100-6.
79. Niilo L. Fluid secretory response of bovine Thiry jejunal fistula to enterotoxin of Clostridium perfringens. Infect Immun 1973; 7: 1-4.
80. Niilo L. Enterotoxigenic Clostridium perfringens type A isolated from intestinal contents of cattle, sheep and chickens. Can J Comp Med 1978; 42: 357-63.
81. Niilo L. Clostridium perfringens in animal disease: a review of current knowledge. Can Vet J 1980; 21: 141-8.
82. Otamiri T. Phospholipase C-mediated intestinal mucosal damage is ameliorated by quinacrine. Food Chem Toxicol 1989; 27: 399-402.
83. Parsons JA, Bannam TL, Devenish RJ, Rood JI. TcpA, an FtsK/SpoIIIE homolog, is essential for transfer of the conjugative plasmid pCW3 in Clostridium perfringens. J Bacteriol 2007; 189: 7782-90.
84. Patton NM, Holmes HT, Riggs RJ, Cheeke PR. Enterotoxemia in rabbits. Lab Anim Sci 1978; 28: 536-40.
85. Payne DW, Williamson ED, Havard H, Modi N, Brown J. Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. FEMS Microbiol Lett 1994; 116: 161-7.
86. Payne D, Williamson ED, Titball RW. The Clostridium perfringens epsilon-toxin. Rev Med Microbiol 1997; 8: 28-30.
87. Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P, Popoff MR. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol 1997; 179: 6480-7.
88. Petit L, Maier E, Gibert M, Popoff MR, Benz R. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem 2001; 276: 15736-40.
89. Petrillo TM, Beck-Sagué CM, Songer JG, Abramowsky C, Fortenberry JD, Meacham L, et al. Enteritis necroticans (pigbel) in a diabetic child. N Engl J Med 2000; 342: 1250-3.
90. Roeder BL, Chengappa MM, Nagaraja TG, Avery TB, Kennedy GA. Experimental induction of abdominal tympany, abomasitis, and abomasal ulceration by intraruminal inoculation of Clostridium perfringens type A in neonatal calves. Am J Vet Res 1988; 49: 201-7.
91. Rood JI, Cole ST. Molecular genetics and pathogenesis of Clostridium perfringens. Microbiol Rev 1991; 55: 621-48.
92. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8: 225-30.
93. Sakurai J, Duncan CL. Purification of beta-toxin from Clostridium perfringens type C. Infect Immun 1977; 18: 741-5.
94. Sakurai J, Duncan CL. Some properties of beta-toxin produced by Clostridium perfringens type C. Infect Immun 1978; 21: 678-80.
95. Sakurai J, Fujii Y, Matsuura M, Endo K. Pharmacological effect of beta toxin of Clostridium perfringens type C on rats. Microbiol Immunol 1981; 25: 423-32.
96. Sakurai J, Fujii Y, Dezaki K, Endo K. Effect of Clostridium perfringens beta toxin on blood pressure of rats. Microbiol Immunol 1984; 28: 23-31.
97. Sakurai J, Nagahama M. Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin. Microb Pathog 1986; 1: 417-23.
98. Sakurai J, Nagahama M, Takahashi T. Contraction induced by Clostridium perfringens epsilon toxin in the isolated rat ileum. FEMS Microbiol Lett 1989; 49: 269-72.
99. Sakurai J, Fujii Y, Shirotani M. Contraction induced by Clostridium perfringens alpha toxin in the isolated rat ileum. Toxicon 1990; 28: 411-8.
100. Sakurai J, Nagahama M, Oda M. Clostridium perfringens alpha-toxin: characterization and mode of action. J Biochem 2004; 136: 569-74.
101. Santin AD, Cané S, Bellone S, Palmieri M, Siegel ER, Thomas M, et al. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin. Cancer Res 2005; 65: 4334-42.
102. Santin AD, Bellone S, Marizzoni M, Palmieri M, Siegel ER, McKenney JK, et al. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE). Cancer 2007; 109: 1312-22.
103. Sarker MR, Carman RJ, McClane BA. Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol Microbiol 1999; 33: 946-58. Erratum in: Mol Microbiol 2000; 35: 249.
104. Satija KC, Narayan KG. Passive bacteriocin typing of strains of Clostridium perfringens type A causing food poisoning for epidemiologic studies. J Infect Dis 1980; 142: 899-902.
105. Shatursky O, Bayles R, Rogers M, Jost BH, Songer JG, Tweten RK. Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect Immun 2000; 68: 5546-51.
106. Sherman S, Klein E, McClane BA. Clostridium perfringens type A enterotoxin induces tissue damage and fluid accumulation in rabbit ileum. J Diarrhoeal Dis Res 1994; 12: 200-7.
107. Shortt SJ, Titball RW, Lindsay CD. An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells. Hum Exp Toxicol 2000; 19: 108-16.
108. Sinclair R, Boone SA, Greenberg D, Keim P, Gerba CP. Persistence of category A select agents in the environment. Appl Environ Microbiol 2008; 74: 555-63.
109. Singh U, Mitic LL, Wieckowski EU, Anderson JM, McClane BA. Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells. J Biol Chem 2001; 276: 33402-12.
110. Smedley JG III, Fisher DG, Sayeed S, Chakrabarti G, McClane BA. The enteric toxins of Clostridium perfringens. Rev Physiol Biochem Pharmacol 2004; 152: 183-204.
111. Songer JG. Clostridial enteric diseases of domestic animals. Clin Microbiol Rev 1996; 9: 2116-34.
112. Songer JG. Bacterial phospholipases and their role in virulence.Trends Microbiol 1997; 5: 156-61.
113. Songer JG, Miskimmins DW. Clostridium perfringens type E enteritis in calves: two cases and a brief review of the literature. Anaerobe. 2004; 10: 239-42.
114. Songer JG, Miskimmins DW. Clostridial abomasitis in calves: Case report and review of the literature. Anaerobe 2005; 11: 290-4.
115. Stackebrandt E, Sproer C, Rainey FA, Burghardt J, Päuker O, Hippe H. Phylogenetic analysis of the genus Desulfotomaculum: evidence for the misclassification of Desulfotomaculum guttoideum and description of Desulfotomaculum orientis as Desulfosporosinus orientis gen. nov., comb. nov. Int J Syst Bacteriol 1997; 47: 1134-9.
116. Stark RL, Duncan CL. Purification and biochemical properties of Clostridium perfringens type A enterotoxin. Infect Immun 1972; 6: 662-73.
117. Stevens DL, Tweten RK, Awad MM, Rood JI, Bryant AE. Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J Infect Dis 1997; 176: 189-95.
118. Stringer MF. Clostridium perfringens type A food poisoning. In: Borriello SP, editor. Clostridia in gastrointestinal disease. Boca Raton, Florida, CRC Press Inc., 1985, p. 117-43.
119. Thompson DR, Parreira VR, Kulkarni RR, Prescott JF. Live attenuated vaccine-based control of necrotic enteritis of broiler chickens. Vet Microbiol 2006; 113: 25-34.
120. Titball RW. Bacterial phospholipases C. Microbiol Rev 1993; 57: 347-66.
121. Tironi-Farinati C, Morris WE, Loidl F, Goldstein J, Dunleavy M, Uzal F, et al. La toxina epsilon de Clostridium perfringens incrementa la permeabilidad del intestino delgado de roedores. LII Reunión Anual de la Sociedad Argentina de Investigación Clínica, 2007, Mar del Plata, Argentina.
122. Uzal FA, Kelly WR. Enterotoxaemia in goats. Veter Res Commun 1996; 20:481-92.
123. Uzal FA, Marcellino RM. Clostridium perfringens in clinically healthy sheep of Patagonia, Argentina. The 6th Biennial Congress of the Anaerobe Society of the Americas, 2002, Park City, USA.
124. Uzal FA, Songer JG. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J Vet Diagn Invest 2008; 20: 253-65.
125. Vance HN. Clostridium perfringens as a pathogen of cattle: A literature review. Can J Comp Med Vet Sci 1967; 31: 248-50.
126. Wallace AJ, Stillman TJ, Atkins A, Jamieson SJ, Bullough PA, Green J, et al. E. coli hemolysin E (HlyE, ClyA, SheA): X-ray crystal structure of the toxin and observation of membrane pores by electron microscopy. Cell 2000; 100: 265-76.
127. Wen Q, McClane BA. Detection of enterotoxigenic Clostridium perfringens type A isolates in American retail foods. Appl Environ Microbiol 2004; 70: 2685-91.
128. Wieckowski EU, Wnek AP, McClane BA. Evidence that an approximately 50-kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically bound Clostridium perfringens enterotoxin. J Biol Chem 1994; 269: 10838-48.
129. Wierup M. Equine intestinal clostridiosis. An acute disease in horses associated with high intestinal counts of Clostridium perfringens type A. Acta Vet Scand Suppl 1977; 62: 1-182.
130. Wierup M, DiPietro JA. Bacteriologic examination of equine fecal flora as a diagnostic tool for equine intestinal clostridiosis. Am J Vet Res 1981; 42: 2167-9.
131. Wojdat E, Kwiatek K, Zdrojewski H, Krupa L. Gas gangrene-case diagnosis. Przegl Epidemiol 2005; 59: 859-63.
132. Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect 2008; 14: 908-34.